Incidence of bleeding symptoms in 100 patients with inherited afibrinogenemia or hypofibrinogenemia.

arin-induced thrombocytopenia. Curr Hematol Rep 2003; 2: 148–57. 4 Shibata S, Harpel PC, Gharavi A, Rand J, Filit H. Autoantibodies to heparin from patients with antiphospholipid antibody syndrome inhibit formation of antithrombin III-thrombin complexes. Blood 1994; 83: 2532–40. 5 Martinuzzo ME, Forastierio RR, Adamczuk Y, Pombo G, Carreras LO. Antiplatelet factor 4–heparin antibodies in patients with antiphospholipid antibodies. Thromb Res 1999; 95: 271–9. 6 Kovacs MJ. Successful treatment of heparin induced thrombocytopenia (HIT) with fondaparinux. Thromb Haemost 2005; 93: 999– 1000. 7 Parody R, Oliver A, Souto JC, Fontcuberta J. Fondaparinux (ARIXTRA) as an alternative anti-thrombotic prophylaxis when there is hypersensitivity to low molecular weight and unfractionated heparins. Haematologica 2003; 88: ECR32. 8 Spinler SA. New concepts in heparin-induced thrombocytopenia: diagnosis and management. J Thromb Thrombolysis 2006; 21: 17–21. 9 Savi P, Chong BH,Greinacher A,Gruel Y,Kelton JG,Warkentin TE, Eichler P, Meuleman D, Petitou M, Herault JP, Carioiu R, Herbert JM. Effect of fondaparinux on platelet activation in the presence of heparin-dependent antibodies: a blinded comparative multicenter study with unfractionated heparin. Blood 2005; 105: 139–44. 10 Girardi G, Redecha P, Salmon JE. Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nat Med 2004; 10: 1222–6.